Background: We previously reported that cannabidiol (CBD), a cannabinoid with a low
toxicity profile, downregulated the expression of the prometastatic gene inhibitor of DNA …

Cannabidiol (CBD) has anti-tumorigenic activity. However, the anti-cancer effect of CBD on
head and neck squamous cell carcinoma (HNSCC) remains unclear. The cytotoxicity of CBD …

Simple Summary Emerging evidence suggests positive outcomes from the use of CBD as a
cancer treatment. CBD can relieve cancer pain and ease the side effects of chemotherapy; …

Cannabinoids have been utilized for recreational and therapeutic purposes for over 4,000
years. As the primary ingredient in exogenous cannabinoids, Cannabidiol (CBD) has drawn …

Colorectal cancer is the third leading cause of cancer incidence and mortality in the United
States. Cannabidiol (CBD), the second most abundant phytocannabinoid in Cannabis …

There is currently a growing interest in the use of cannabidiol (CBD) to alleviate the
symptoms caused by cancer, including pain, sleep disruption, and anxiety. CBD is often self …

Introduction: Glioblastoma (GBM) is the most common invasive brain tumor composed of
diverse cell types with poor prognosis. The highly complex tumor microenvironment (TME) …

In the present study, we found that CBD inhibited U87-MG and T98G cell proliferation and
invasiveness in vitro and caused a decrease in the expression of a set of proteins …

Recently, cannabinoids, such as cannabidiol (CBD) and Δ 9-tetrahydrocannabinol (THC),
have been the subject of intensive research and heavy scrutiny. Cannabinoids encompass a …

The Cannabis plant contains over 100 phytocannabinoids and hundreds of other
components. The biological effects and interplay of these Cannabis compounds are not fully …